Kobayashi Pharmaceutical Co., Ltd. (4967.T)
Tokyo · JPY · Consumer Defensive · Household & Personal Products
¥7,099 (-0.99%) as of
Key statistics
- Market cap
- 527.73B
- P/E (TTM)
- 324.90
- Forward P/E
- 30.07
- EPS (TTM)
- 21.85
- Dividend yield
- 1.46%
- 52-week range
- 5,030.00 – 7,388.00
- Beta
- 0.20
- Revenue (TTM)
- 167.47B
- Profit margin
- 0.97%
- Analyst target
- ¥5,521.25
- Volume
- 146.40k
About Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Headquarters
- Osaka, Japan
- Employees
- 3,731
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.